RICHARD FLYGARE: Open Payments
NPI 1194819748 · COEUR D'ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 10 payments from 5 companies in 2025. Trend: 2023 $231 · 2024 $286 · 2025 $274
Food & beverage: $199Education: $75
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $120 |
| ABBVIE INC. | 3 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Amgen Inc. | 1 | $31 |
| Lilly USA, LLC | 1 | $25 |
Products named: TREMFYA, RINVOQ, Otezla, COSENTYX, EBGLYSS.
Industry payments across ID — which companies pay providers there.
